Page 315 - IJB-9-3
P. 315

International Journal of Bioprinting                            Bioprinted stem cell niche regenerates muscles
















































            Figure 5. Implantation of GFP-MPC-seeded DLL1-DermaMatrix construct into mdx muscle resulted in improved cell engraftment. (A) Schematic
            demonstration of the in vivo experiment of the implantation of 3D constructs into mice (control and DLL1). (B) GFP-labeled MPCs from WT mice were
            seeded into DermaMatrix constructs with or without bioprinted DLL1 (4 × 10  cells in DermaMatrix construct of 4 × 4 × 1 mm in dimensions). Ten
                                                               4
            days after the implantation of MPC-seeded DLL1-DermaMatrix or MPC-seeded control DermaMatrix constructs, an improved cell engraftment was
            observed in the muscle tissue implanted with the MPC-seeded DLL1-DermaMatrix constructs. There were more GFP-positive MPCs (yellow arrow head)
            and dystrophin-positive myofibers (white arrows) in DLL1-DermaMatrix construct group. (C) Proposed mechanism for the improved muscle stem cell
            engraftment by bioprinting of Notch activator in 3D construct to serve as stem cell niche.

            in  skeletal  muscle  declines  with  age  in  both  mice  and   biodegradable 3D construct to serve as artificial muscle
            humans, and this decline is responsible for the depletion of   stem cell niche. DLL1-DermaMatrix construct seeded with
            functional muscle stem cells [11-13] . When compared to WT   MPCs was implanted into the limb muscles (gastrocnemius)
            mice (6-month-old), we observed a down-regulation in   of mdx/scid mice, and the number of dystrophin-positive
            the expression of key Notch signaling factors (i.e., Notch1,   myofibers was found to be obviously increased 10 days after
            Hes1, Jagged1 and DLL1) in the skeletal muscle of mdx   implantation when compared to  the  muscles  implanted
            mice. Therefore, when performing stem cell therapy for   with control DermaMatrix construct. Bioprinting of Notch
            DMD, an ECM construct containing muscle stem cells and   ligands within 3D construct is expected to lead to the
            Notch activating factors  that allow for the sustainability   maintenance  of  stemness  and  improved  proliferation  of
            and self-renewal of tissue-resident stem cell would  be   both resident and seeded stem cells, and the antiapoptotic
            extremely attractive.                              effect of Notch activation is expected to increase cell
                                                               survival. These stem cells can then migrate to locations
               We  have  developed  a  novel  strategy  for  repairing   distant from the site of initial implantation before they
            dystrophic muscle, by bioprinting a recombinant    differentiate and fuse into myofibers, thus generating a
            DLL1 protein [DLL1 (mouse): Fc (human) (rec)] into   larger engraftment. Also, the Notch ligands bioprinted in

            Volume 9 Issue 3 (2023)                        307                         https://doi.org/10.18063/ijb.711
   310   311   312   313   314   315   316   317   318   319   320